COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 136 filers reported holding COGENT BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,639,411 | -17.9% | 475,837 | -0.3% | 0.18% | -7.7% |
| Q2 2023 | $5,648,627 | +9.7% | 477,080 | 0.0% | 0.20% | +9.5% |
| Q1 2023 | $5,147,693 | -12.9% | 477,080 | -6.7% | 0.18% | -20.4% |
| Q4 2022 | $5,911,668 | -22.5% | 511,390 | 0.0% | 0.22% | -29.5% |
| Q3 2022 | $7,630,000 | -6.2% | 511,390 | -43.3% | 0.32% | +3.9% |
| Q2 2022 | $8,131,000 | +3.3% | 901,412 | -14.2% | 0.31% | +26.9% |
| Q1 2022 | $7,870,000 | -12.7% | 1,050,699 | 0.0% | 0.24% | -3.6% |
| Q4 2021 | $9,015,000 | +9.1% | 1,050,699 | +7.0% | 0.25% | +7.7% |
| Q3 2021 | $8,261,000 | +23.3% | 982,298 | +18.9% | 0.23% | +50.3% |
| Q2 2021 | $6,700,000 | +4.3% | 826,119 | +12.9% | 0.16% | +8.4% |
| Q1 2021 | $6,426,000 | +20.3% | 731,903 | +53.9% | 0.14% | +16.3% |
| Q4 2020 | $5,342,000 | – | 475,705 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $17,507,000 | 6.26% |
| COMMODORE CAPITAL LP | 760,025 | $8,535,000 | 4.64% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $18,222,000 | 3.12% |
| Ghost Tree Capital, LLC | 1,100,000 | $12,353,000 | 2.75% |
| Logos Global Management LP | 1,920,500 | $21,567,000 | 1.85% |
| Altium Capital Management LP | 432,563 | $4,858,000 | 1.81% |
| VR Adviser, LLC | 1,088,817 | $12,227,000 | 1.80% |
| Atlas Venture Associates IX, LLC | 916,196 | $10,289,000 | 1.63% |
| Atlas Venture Associates XI, LLC | 916,196 | $10,289,000 | 1.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 235,066 | $2,640,000 | 1.53% |